USSTOCK.TODAY
Market Closed
Log in Sign up

Evogene Ltd(EVGN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

EVGN
EVGN
Evogene Ltd
At close Nov 19 at 4:00 PM ET (Korea 11/20 06:00)
$0.33
-0.02 ▼ -5.70%
Nov 19 at 4:02 PM ET (Korea 11/20 06:02)
$0.31
+0.00 -0.96%

Full metrics table

Index ⓘ -P/E ⓘ -EPS (ttm) ⓘ -0.91Insider Own ⓘ 36.98%Shs Outstand ⓘ 13.5MPerf Week ⓘ -8.57%
Market Cap ⓘ 0.01BForward P/E ⓘ -EPS next Y ⓘ 45.45%Insider Trans ⓘ 23.29%Shs Float ⓘ 11.4MPerf Month ⓘ -10.89%
Enterprise Value ⓘ 0.01BPEG ⓘ -EPS next Q ⓘ -0.2Inst Own ⓘ 2.87%Short Float ⓘ 0.62%Perf Quarter ⓘ -41.32%
Income ⓘ -0.01BP/S ⓘ 4.55EPS this Y ⓘ -2.08%Inst Trans ⓘ 4.17%Short Ratio ⓘ 0.05Perf Half Y ⓘ -52.4%
Sales ⓘ 0.00BP/B ⓘ -EPS next 5Y ⓘ 25.25%ROA ⓘ -71.03%Short Interest ⓘ 0.07MPerf YTD ⓘ -70%
Book/sh ⓘ -0.24P/C ⓘ 0.64EPS past 3/5Y ⓘ 44.96% 33.52%ROE ⓘ -52W High ⓘ -73.81% ($1.26)Perf Year ⓘ -71.79%
Cash/sh ⓘ 0.52P/FCF ⓘ -Sales past 3/5Y ⓘ 32.01% 29.94%ROIC ⓘ -52W Low ⓘ 31.86% ($0.25)Perf 3Y ⓘ -95%
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ 59.44%Gross Margin ⓘ -14.15%Volatility(W/M) ⓘ 12.97% 11.54%Perf 5Y ⓘ -98.45%
Dividend TTM ⓘ -EV/Sales ⓘ 5.93Sales Y/Y TTM ⓘ -80.59%Oper. Margin ⓘ -1019.82%ATR (14) ⓘ 0.05Perf 10Y ⓘ -99.44%
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 3.54EPS Q/Q ⓘ 76.53%Profit Margin ⓘ -694.19%RSI (14) ⓘ 43.38Recom ⓘ 1
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 3.57Sales Q/Q ⓘ -60.75%SMA20 ⓘ -7.09% ($0.36)Beta ⓘ 1.42Target Price ⓘ $2.15
Payout ⓘ -Debt/Eq ⓘ -Earnings ⓘ 2026/11/18SMA50 ⓘ -16.86% ($0.4)Rel Volume ⓘ 0.13Prev Close ⓘ $0.35
Employees ⓘ 52LT Debt/Eq ⓘ -EPS/Sales Surpr. ⓘ -SMA200 ⓘ -46.36% ($0.62)Avg Volume(3M) ⓘ 1.40MPrice ⓘ $0.33
IPO ⓘ 2008/3/5Option/Short ⓘ No/NoTrades ⓘ 447Volume ⓘ 175,991Change ⓘ -5.7%
Company
EVGN EVGNEvogene Ltd | NASD | Biotechnology Deep dive

An Israel-based AI and ag-biotech company that designs small molecules using generative AI and big data-driven computational chemistry, supplying them to pharmaceutical and agricultural companies. Its core platform, ChemPass AI™, accelerates the discovery of new molecules for pharmaceutical and crop protection applications, and the company is collaborating with Google Cloud to build a foundation model for small molecule design.

Quote

Over the past 1 year, on the lower side

74% below its 1-year high.

Now $0.33
52w low$0.2552w high$1.26
52W Range8%
Volume ⓘ 175,991

Traded less than usual. That is 13% of its average volume.

C
Overall · average, with some caution
We judged 7 of the 8 questions below. 1 rate excellent and 3 need caution.
Not applicable: dividends.
Peer comparison Biotechnology

It ranks #531 of 598 in the industry

Based on market cap of $6M.

FAQ

FAQ

What kind of company is EVGN?

EVGN belongs to the Healthcare sector and operates in the Biotechnology industry.

What is the market cap of EVGN?

The market cap of EVGN is approximately $6M, ranking 5,514 within its sector.

What is the 52-week high and low for EVGN?

EVGN has recorded a 52-week high of $1.26 and a low of $0.25.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels